Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study
Article in Cancers (February 2023)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Clustering and Stochastic Simulation Optimization for Outpatient Chemotherapy Appointment Planning and Scheduling
Article in International Journal of Environmental Research and Public Health (November 2022)
Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test in Node-Negative Early Breast Cancer
Article in ClinicoEconomics and Outcomes Research (September 2022)